Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Neuroblastoma 2017 NINDS 1R01NS094218-01A1 Focal Sustained Release Chemotherapy-Loaded Biomaterials at Tumor Sites KAPLAN, DAVID TUFTS UNIVERSITY MEDFORD MA $355,019
Neuroblastoma 2017 NCI 5R21CA187548-02 Second generation MIBG analogs that cotarget DNA for high risk neuroblastoma BARANOWSKA-KORTYLEWICZ, JANINA UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $163,669
Neuroblastoma 2017 NCI 5P01CA094237-15 7520 VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,519
Neuroblastoma 2017 NCI 5P01CA094237-15 7522 ENGINEERING T CELLS FOR PANCREATIC CANCER HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $254,484
Neuroblastoma 2017 NCI 5P01CA094237-15 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,506
Neuroblastoma 2017 NCI 5P30CA008748-51 7572 Research Pharmacy MULLER, RAYMOND SLOAN-KETTERING INST CAN RESEARCH NY $239,419
Neuroblastoma 2017 NCI 1R01CA211328-01 Regulation of the LIN28/let-7 pathway in cancer GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $404,888
Neuroblastoma 2017 NCI 1R01CA204093-01A1 A First-in-Human Pilot Study of 18F-MFBG Imaging for Evaluation of Neuroblastoma PANDIT-TASKAR, NEETA SLOAN-KETTERING INST CAN RESEARCH NY $392,078
Neuroblastoma 2017 NCI 5P30CA021765-38 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $256,191
Neuroblastoma 2017 NCI 5P30CA014089-42 5251 Core-009 GRUBER, STEPHEN UNIVERSITY OF SOUTHERN CALIFORNIA CA $570,611
Neuroblastoma 2017 NCI 5R01CA180692-03 Role of LMO1 in Neuroblastoma Initiation and Maintenance MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $606,838
Neuroblastoma 2017 NCI 5R01CA197336-02 Transcriptional CDKs as therapeutic targets in MYC-dependent cancers GEORGE, RANI DANA-FARBER CANCER INST MA $407,748
Neuroblastoma 2017 NCI 5K08CA194162-03 The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas SCHNEPP, ROBERT EMORY UNIVERSITY GA $168,264
Neuroblastoma 2017 NCI 5R01CA197903-02 Molecular Characteristics of Treatment-resistant High-risk Neuroblastoma ZHONG, JOHN UNIVERSITY OF SOUTHERN CALIFORNIA CA $378,357
Neuroblastoma 2017 NCI 5K99CA197484-02 Identification of novel cooperating partners of MYCN in neuroblastoma tumorigenesis HUANG, MILLER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $160,773
Neuroblastoma 2017 NCI 5R01CA172067-06 Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma DUBOIS, STEVEN DANA-FARBER CANCER INST MA $363,425
Neuroblastoma 2017 NCI 5R01CA116548-12 THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA METELITSA, LEONID BAYLOR COLLEGE OF MEDICINE TX $249,637
Neuroblastoma 2017 NINDS 5R01NS088355-03 Targeting BET-bromodomains in neuroblastoma WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $675,172
Neuroblastoma 2017 NCI 5R01CA166749-06 The Role of Growth Factor Receptor Trafficking in Tumorigenesis ZAGE, PETER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $315,213
Neuroblastoma 2017 NIDDK 5R01DK061470-14 Surgical Studies on the Role on Gastrin-releasing Peptide in Neuroblastoma CHUNG, DAI VANDERBILT UNIVERSITY MEDICAL CENTER TN $409,278
Neuroblastoma 2017 NCI 5R01CA124709-10 The Genetic Basis of Neuroblastoma Tumorigenesis MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $614,290
Neuroblastoma 2017 NCI 5R01CA193890-03 HAUSP inhibitors in p53-wild type and p53-mutant tumors GU, WEI COLUMBIA UNIVERSITY HEALTH SCIENCES NY $366,000
Neuroblastoma 2017 NIA 5R21AG052195-02 Screening for enhancers of sAPPalpha JOHN, VARGHESE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $192,500
Neuroblastoma 2017 NCI 5U10CA180884-04 COG NCTN Solid Malignancy Integrated Translational Science Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $400,000
Neuroblastoma 2017 NCI 5R01CA140198-09 Targeting Oncogenic ALK Signaling in Neuroblastoma MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $374,324
Neuroblastoma 2017 OD 1S10OD021818-01A1 PRISM: Precision Radiotherapy and Imaging of Small Mammals FADDEGON, BRUCE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $530,754
Neuroblastoma 2017 NINDS 5R21NS094654-02 TMEM108 IS A NOVEL TARGET IN NEUROBLASTOMA YANG, JIANHUA BAYLOR COLLEGE OF MEDICINE TX $237,750
Neuroblastoma 2017 NIGMS 2SC3GM102050-04 Formulation of Fenretinide Nanoparticles for Enhanced Bioavailability BOSTANIAN, LEVON XAVIER UNIVERSITY OF LOUISIANA LA $105,768
Neuroblastoma 2017 NCI 1R01CA215452-01 Identifying and targeting oncogenic Myc enhancer control in pediatric tumors LIN, CHARLES BAYLOR COLLEGE OF MEDICINE TX $362,569
Neuroblastoma 2017 NCI 1R01CA215610-01 ABT-199 based therapies to treat neuroblastoma FABER, ANTHONY VIRGINIA COMMONWEALTH UNIVERSITY VA $371,856
Neuroblastoma 2017 NCI 5R01CA057138-26 Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $635,460
Neuroblastoma 2017 NCI 5U01CA199287-03 Pediatric Preclinical Testing Consortium MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $357,000
Neuroblastoma 2017 NCI 5R01CA174808-04 Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells SHOHET, JASON BAYLOR COLLEGE OF MEDICINE TX $326,348
Neuroblastoma 2017 NCI 5R01CA197964-03 Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor KITLINSKA, JOANNA GEORGETOWN UNIVERSITY DC $348,597
Neuroblastoma 2017 NCI 5P30CA125123-11 8013 Cancer Cell and Gene Therapy Program (Project-005) HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $43,684
Neuroblastoma 2017 NIGMS 5F32GM120956-02 Role of Ubiquitination in Neurocristopathies and Neural Crest-Derived Cancers MARK, KEVIN UNIVERSITY OF CALIFORNIA BERKELEY CA $57,066
Neuroblastoma 2017 NCI 2R01CA148688-06A1 The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma GEORGE, RANI DANA-FARBER CANCER INST MA $413,844
Neuroblastoma 2017 NCI 1R01CA207983-01A1 Exosomes in tumor cell-mesenchymal stromal cell interaction DECLERCK, YVES CHILDREN'S HOSPITAL OF LOS ANGELES CA $423,016
Neuroblastoma 2017 NICHD 1R03HD089190-01A1 Examining Signals That Sculpt Cranial Neural Crest Migration KULESA, PAUL STOWERS INSTITUTE FOR MEDICAL RESEARCH MO $82,500
Neuroblastoma 2017 NCI 5R01CA204974-02 Structural Variation in Neuroblastoma DISKIN, SHARON CHILDREN'S HOSP OF PHILADELPHIA PA $384,300
Neuroblastoma 2017 NCI 5R35CA197078-03 Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome SONDEL, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $917,202
Neuroblastoma 2017 NIDCD 5K23DC014291-02 Prevention of Cisplatin-induced Hearing Loss in Children with Cancer ORGEL, ETAN CHILDREN'S HOSPITAL OF LOS ANGELES CA $193,191
Neuroblastoma 2017 NCI 5K22CA201103-02 Targeting nutrient-sensing pathways in cancer LAZARUS, MICHAEL ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $191,360
Neuroblastoma 2017 NIGMS 5P30GM106396-05 8530 Animal Model Core CHESNEY, JASON UNIVERSITY OF LOUISVILLE KY $235,461
Neuroblastoma 2017 NINDS 5U01NS082328-04 Neural Stem Cell Mediated CE-CPT11 Therapy for Neuroblastoma ABOODY, KAREN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $949,003
Neuroblastoma 2017 NCI 5P30CA093373-15 8697 Clinical Protocol and Data Management KELLY, KAREN UNIVERSITY OF CALIFORNIA AT DAVIS CA $292,034
Neuroblastoma 2017 NCI 5R35CA210030-02 Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer STEGMAIER, KIMBERLY DANA-FARBER CANCER INST MA $1,046,441
Neuroblastoma 2017 NCI 5R00CA178189-05 Pathogenic Roles of SHP2 & PTPRD Tyrosine Phosphatases in High-Risk Neuroblastoma ZHU, SHIZHEN MAYO CLINIC ROCHESTER MN $249,000
Neuroblastoma 2017 NCI 5R01CA195732-02 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $348,844
Neuroblastoma 2017 NINDS 5R01NS095411-03 Targeting Tumors with NF1 Loss SANCHEZ, YOLANDA DARTMOUTH COLLEGE NH $544,581
Neuroblastoma 2017 NCI 5R01CA182526-04 Targeting Neuroblastoma with armed T cells LUM, LAWRENCE UNIVERSITY OF VIRGINIA VA $765,563
Neuroblastoma 2017 NCI 5R50CA211437-02 Revealing cancer metabolism via mass spectrometry and isotope tracers LU, WENYUN PRINCETON UNIVERSITY NJ $108,427
Neuroblastoma 2017 NCI 5F99CA212487-02 The role of Lin28/let 7 pathway in Wilms' tumor YERMALOVICH, ALENA HARVARD UNIVERSITY MA $31,994
Neuroblastoma 2017 NCI 1P01CA217959-01 5991 Targeting Evolving Therapy Resistance MOSSE, YAEL CHILDREN'S HOSP OF PHILADELPHIA PA $328,133
Neuroblastoma 2017 NCI 1P01CA217959-01 5992 Exploiting Therapeutic Vulnerabilities WEISS, WILLIAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,133
Neuroblastoma 2017 NCI 1P01CA217959-01 5994 Targeting the Pro-tumorigenic Microenvironment DECLERCK, YVES CHILDREN'S HOSPITAL OF LOS ANGELES CA $328,134
Neuroblastoma 2017 NCI 1P01CA217959-01 5995 Enhancing the Potency and Durability  of Immunotherapies SEEGER, ROBERT CHILDREN'S HOSPITAL OF LOS ANGELES CA $328,134
Neuroblastoma 2017 NCI 1P01CA217959-01 5996 Administrative Core MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $328,134
Neuroblastoma 2017 NCI 1P01CA217959-01 5997 Clinical Trials and Translation MATTHAY, KATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,134
Neuroblastoma 2017 NCI 1P01CA217959-01 5998 Biostatics GROSHEN, SUSAN UNIVERSITY OF SOUTHERN CALIFORNIA CA $328,134
Neuroblastoma 2017 NCI 5P30CA014089-42 8290 Tumor Microenvironment Research Program (Project-003) DECLERCK, YVES UNIVERSITY OF SOUTHERN CALIFORNIA CA $61,950
Neuroblastoma 2017 NCI 1R21CA219352-01 Role of m6A mRNA methylation in Neuroblastoma GREGORY, RICHARD BOSTON CHILDREN'S HOSPITAL MA $246,472
Neuroblastoma 2017 NCI 1R15CA213199-01A1 Discovery of New Differentiation Agents for Neuroblastoma Therapy DU, LIQIN TEXAS STATE UNIVERSITY TX $461,575
Neuroblastoma 2017 NCI 1R03CA212802-01A1 The role of JMJD6 in MYC-mediated neuroblastoma YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $89,750
Neuroblastoma 2017 NIGMS 2R01GM066233-13 The plasma membrane monoamine transporter (PMAT): expression and role in mIBG disposition in neuroblastoma WANG, JOANNE UNIVERSITY OF WASHINGTON WA $375,785
Neuroblastoma 2017 NCI 1R35CA220500-01 Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes MARIS, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $683,163
Neuroblastoma 2017 NCI 1R01CA215753-01A1 Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma FABBRI, MULLER CHILDREN'S HOSPITAL OF LOS ANGELES CA $391,698
Neuroblastoma 2017 NIGMS 3F32GM120956-01S1 Role of Ubiquitination in Neurocristopathies and Neural Crest-Derived Cancers MARK, KEVIN UNIVERSITY OF CALIFORNIA BERKELEY CA $1,800
Neuroblastoma 2017 NCI 3UM1CA097452-15S1 Pediatric Phase 1/Pilot Consortium WEIGEL, BRENDA CHILDREN'S HOSP OF PHILADELPHIA PA $1,530,543
Neuroblastoma 2017 NCI 3R01CA215452-01S1 Identifying and targeting oncogenic Myc enhancer control in pediatric tumors LIN, CHARLES BAYLOR COLLEGE OF MEDICINE TX $14,309
Neuroblastoma 2017 NCI 1ZIABC010390-18 Role of Neurotrophins in the Development of the Mammalian Nervous System TESSAROLLO, LINO NIH $731,359
Neuroblastoma 2017 NCI 1ZIABC010788-11 Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma THIELE-GALETTO, CAROL NIH $926,748
Neuroblastoma 2017 NCI 1ZIABC010789-11 Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma THIELE-GALETTO, CAROL NIH $499,018
Neuroblastoma 2017 NCI 1ZIABC010806-11 Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma KHAN, JAVED NIH $237,202
Neuroblastoma 2017 NCI 1ZIABC010891-10 Development of new antibody-based cancer therapies HO, MITCHELL NIH $1,311,816
Neuroblastoma 2017 NCI 1ZIABC010998-10 Identification of Novel Mutations In Pediatric Cancers KHAN, JAVED NIH $711,607
Neuroblastoma 2017 NCI 1ZIASC010366-17 Identification of Genes for Predicting Prognosis in Pediatric Cancers KHAN, JAVED NIH $237,202
Neuroblastoma 2017 NCI 1ZICBC011567-04 HiTIF Microscopy Core Facility PEGORARO, GIANLUCA NIH $1,194,956
Neuroblastoma 2017 NCI 1ZIEBC011516-05 Pediatric Oncology Branch Clinical Care and Education GLOD, JOHN NIH $4,988,540
Neuroblastoma 2017 NIAAA 1ZIAAA000284-28 Alterations In Lipid Metabolism In The Nervous System By Ethanol KIM, HEE-YONG NIH $1,768,029
Neuroblastoma 2017 NCI 261201500003I-0-26100041-1 IGF::OT::IGF Human Tumor Atlas Pilot Program AGARWAL, RACHANA LEIDOS BIOMEDICAL RESEARCH, INC. MD $15,241,462


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer